tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Protagonist Therapeutics Inc (PTGX)
NASDAQ:PTGX
US Market
PTGX
Protagonist Therapeutics
RESEARCH TOOLSreports

Protagonist Therapeutics (PTGX) Stock News & Sentiment

Compare
730 Followers
Protagonist Therapeutics: Advancing Multi-Asset Inflammation and Obesity Pipeline with Strong Cash Runway Supports Buy Rating
Premium
Ratings
Protagonist Therapeutics: Advancing Multi-Asset Inflammation and Obesity Pipeline with Strong Cash Runway Supports Buy Rating
18d ago
PTGX
Protagonist Therapeutics Highlights Diversified Pipeline and Partnerships
Premium
Company Announcements
Protagonist Therapeutics Highlights Diversified Pipeline and Partnerships
18d ago
8K
PTGX
Advancing, De-Risked Pipeline and Near-Term Regulatory Catalysts Underpin Protagonist Therapeutics Buy Rating
Premium
Ratings
Advancing, De-Risked Pipeline and Near-Term Regulatory Catalysts Underpin Protagonist Therapeutics Buy Rating
24d ago
PTGX
Promising Clinical Data and Strategic Collaborations Drive Buy Rating for Protagonist Therapeutics
Premium
Ratings
Promising Clinical Data and Strategic Collaborations Drive Buy Rating for Protagonist Therapeutics
2M ago
PTGX
Protagonist Therapeutics Advances Pipeline Amid Financial Loss
Premium
Company Announcements
Protagonist Therapeutics Advances Pipeline Amid Financial Loss
3M ago
PTGX
Promising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating
Premium
Ratings
Promising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating
3M ago
PTGX
PTGX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PTGX Earnings this Week: How Will it Perform?
3M ago
PTGX
More PTGX News >

PTGX News on the Web

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Unicycive Therapeutics (UNCY)
TipRanks News
Bullish
Protagonist Therapeutics price target raised to $117 from $80 at H.C. Wainwright
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Sarepta Therapeutics (SRPT) and Protagonist Therapeutics (PTGX)
TipRanks News
Bullish
Top Brass at Protagonist Therapeutics Quietly Cash In on Major Stock Moves
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Protagonist Therapeutics (PTGX), CG Oncology, Inc. (CGON)
TipRanks News
Bullish
H.C. Wainwright Sticks to Their Buy Rating for Protagonist Therapeutics (PTGX)
TipRanks News
Neutral
Protagonist Therapeutics: Advancing Multi-Asset Inflammation and Obesity Pipeline with Strong Cash Runway Supports Buy Rating
TipRanks News
Bullish
Protagonist Therapeutics Highlights Diversified Pipeline and Partnerships
TipRanks News
Bullish

News Score - Last 7 Days

Positive
PTGX
Sector Average
Media Buzz
This Week3 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average74%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PTGX’s Media Buzz Sentiment?
3 articles about PTGX were published this week. In an average week, 3 articles are published.
    What is PTGX’s weekly average amount of articles?
    In an average week, 3 articles about PTGX are published.
      What is PTGX’s News Sentiment?
      100% of articles about PTGX were positive this week, compared to its sector average of 74%.
        Healthcare Stocks that are Trending in the News
        IMAImageneBio
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        QNCXQuince Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week